NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Laicuinuo LCN? Mail in a sample (US only) and let us test it.

Test my supply
+4 more ↓
58%
Finnrick rating
#454 of 500 ranked vendors
28 of 48 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Laicuinuo LCN's purity-focus record is strongest on GHK-Cu and Tirzepatide, with generally solid identity/purity evidence but notable Tirzepatide fill volatility. Retatrutide remains mixed despite later passes, with identity failures, extreme overfills and a recent purity miss; BPC-157 and Tesamorelin are sparse and uncertain.

methodology →
vendor intelligence report
Vendor Intelligence Report: Laicuinuo LCN

Corporate records point to a UK Xingruida wrapper in strike-off posture, while HK/CN registry searches do not confirm the storefront’s branding. Mirrored domains, shared infrastructure, and direct-payment rails create the authentication story behind the lab numbers.

17 pages4 risk factors assessed2 Jul 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%24 Oct 2025: 58%24 Oct 2025: 58%18 Nov 2025: 58%6 Dec 2025: 57%7 Jan 2026: 57%20 Feb 2026: 59%20 Feb 2026: 60%2 Mar 2026: 56%2 Mar 2026: 62%2 Mar 2026: 63%2 Mar 2026: 63%2 Mar 2026: 63%5 Mar 2026: 63%19 Mar 2026: 63%19 Mar 2026: 63%5 May 2026: 63%11 May 2026: 62%2 Jun 2026: 61%10 Jul 2026: 61%13 Jul 2026: 62%13 Jul 2026: 63%20 Jul 2026: 62%20 Jul 2026: 61%2 Aug 2026: 61%3 Aug 2026: 60%25 Aug 2026: 60%25 Aug 2026: 59%4 Sep 2026: 59%5 Sep 2026: 59%5 Sep 2026: 58%15 Sep 2026: 58%16 Sep 2026: 57%24 Sep 2026: 59%24 Sep 2026: 58%24 Sep 2026: 57%30 Sep 2026: 57%30 Sep 2026: 58%5 Oct 2026: 57%29 Oct 2026: 58%10 Nov 2026: 58%17 Nov 2026: current 58%58%63%58%Oct 25Nov 26
Peptide testing

Ordered peptides from Laicuinuo LCN? Mail in a sample (US only) and let us test it.

Test my supply
Laicuinuo LCN test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
10 Nov 2026
Pass
Retatrutide
lab nameView COA
29 Oct 2026
Pass
Retatrutide
lab nameView COA
5 Oct 2026
Fail
Retatrutide
lab nameView COA
30 Sep 2026
Pass
Retatrutide
lab nameView COA
30 Sep 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Fail
BPC-157
lab nameView COA
24 Sep 2026
Fail
GHK-Cu
lab nameView COA
24 Sep 2026
Fail
Tirzepatide
lab nameView COA
16 Sep 2026
Fail
Tirzepatide
lab nameView COA
15 Sep 2026
Pass
GHK-Cu
lab nameView COA
1-10 of 48

About Laicuinuo LCN test results from Finnrick

Laicuinuo LCN is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 48 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Laicuinuo LCN peptides in this dataset are BPC-157 (3 tests), CJC-1295 (3 tests) and GHK-Cu (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 48 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Laicuinuo LCN? Mail in a sample (US only) and let us test it.

Test my supply